Phoenix Children's is currently participating in nearly 200 research studies. Below is just a small sampling of active studies.
- Fontan Follow-Up Study: Altitude vs. Attitude
- Car-Seat Challenge Testing in Pediatric Cardio-thoracic Surgical Patients
- Clinical Outcomes of Chemotherapy Induced Hyperglycemia in the Pediatric Setting
- Co-Morbidities Seen with Long Term Observation of a Large Cohort of Patients with Microvillus Inclusion Disease
- The Epidemiology of Pediatric Inflammatory Bowel Disease in the Western Region of North America
- National Marrow Donor Program (NMDP) Protocol for a Research Database for Allogeneic Unrelated Hematopoetic Stem Cell Transplantation
- Phase I Study of Liposomal Annamycin in Children and Young Adults with Refractory or Relapsed Acute Lymphocytic Leukemia or Acute Myelogenous Leukemia
- AAML0431: The Treatment of Down Syndrome Children with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Under the Age of 4 Years
- Neurodevelopmental Outcome Following Congenital Heart Surgery: Evaluation of cooling and antegrade cerebral perfusion
- Treatment Protocol for use of Anascorp in Patients with Scorpion Sting Envenomation
On Dec. 4, 2012, Phoenix Children’s Hospital announced the creation of the Ronald A. Matricaria Institute of Molecular Medicine, with the goal to unlock genetic codes and develop drug therapies to improve the outcome for thousands of young patients. Learn more about the Institute.